"Insulin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).
| Descriptor ID |
D007328
|
| MeSH Number(s) |
D06.472.699.587.200.500.625 D12.644.548.586.200.500.625
|
| Concept/Terms |
Insulin- Insulin
- Insulin, Regular
- Regular Insulin
- Soluble Insulin
- Insulin, Soluble
|
Below are MeSH descriptors whose meaning is more general than "Insulin".
Below are MeSH descriptors whose meaning is more specific than "Insulin".
This graph shows the total number of publications written about "Insulin" by people in this website by year, and whether "Insulin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 3 | 5 | 8 |
| 2003 | 3 | 1 | 4 |
| 2004 | 6 | 1 | 7 |
| 2005 | 4 | 5 | 9 |
| 2006 | 2 | 8 | 10 |
| 2007 | 3 | 5 | 8 |
| 2008 | 2 | 2 | 4 |
| 2009 | 6 | 4 | 10 |
| 2010 | 3 | 5 | 8 |
| 2011 | 7 | 9 | 16 |
| 2012 | 5 | 1 | 6 |
| 2013 | 6 | 6 | 12 |
| 2014 | 4 | 16 | 20 |
| 2015 | 6 | 4 | 10 |
| 2016 | 4 | 7 | 11 |
| 2017 | 3 | 5 | 8 |
| 2018 | 1 | 4 | 5 |
| 2019 | 8 | 5 | 13 |
| 2020 | 4 | 7 | 11 |
| 2021 | 2 | 7 | 9 |
| 2022 | 2 | 5 | 7 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 2 | 4 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin" by people in Profiles.
-
Batrakoulis A, Perivoliotis K, Courneya KS, Schmitz KH, Schwartz AL, Al-Mhanna SB, Liapis N, Tzovaras G, Baloyiannis I. Comparative Efficacy of Various Exercise Types on Psychophysiological Outcomes in Colorectal Cancer Survivors: A Network Meta-Analysis. Med Sci Sports Exerc. 2026 Apr 01; 58(4):670-682.
-
Diaz-Cotto E, Ramirez-Marrero FA, Leyva-Jord?n CA. Grip Strength and Anthropometric Characteristics among Hispanic Children and Adolescents with Obesity and Insulin Resistance. P R Health Sci J. 2026 Mar; 45(1):23-27.
-
Abbah QS, Amenyenu E, Aryee ANA, Onuh JO. Functional Carbohydrates as Innovative Food Ingredients in Diabetes Management: A Succinct Review. J Food Sci. 2025 Jul; 90(7):e70372.
-
Sobhani NC, Huang Y, Venkatesh KK, Wright JD, Friedman AM, Wen T. Diabetes Technology Use in Pregnancies with Type 1 Diabetes in the United States from 2009 to 2020. Am J Perinatol. 2026 03; 43(4):453-460.
-
Wang L, Curran GL, Zhong R, Xue Z, Veerareddy V, Thieschafer J, Min PH, Li L, Lowe VJ, Kandimalla KK. Amyloid beta peptides inhibit glucose transport at the blood-brain barrier by disrupting the insulin-AKT pathway. J Cereb Blood Flow Metab. 2025 Oct; 45(10):1961-1979.
-
Wang Z, Veerareddy V, Tang X, Thompson KJ, Krishnan S, Kalari KR, Kandimalla KK. QSP Modeling Shows Pathological Synergism Between Insulin Resistance and Amyloid-Beta Exposure in Upregulating VCAM1 Expression at the BBB Endothelium. CPT Pharmacometrics Syst Pharmacol. 2025 Mar; 14(3):561-571.
-
Davidson MB. The Effective Use by Primary Care Clinicians of a Comprehensive Computerized Insulin Dose Adjustment Algorithm. J Diabetes Sci Technol. 2026 May; 20(3):1021-1027.
-
Davidson MB, Davidson SJ. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
-
Zhou AL, Swaminathan SK, Salian VS, Wang L, Curran GL, Min HK, Lowe VJ, Kandimalla KK. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier. Mol Pharm. 2024 May 06; 21(5):2176-2186.
-
Chang L, Goff HD, Ding C, Liu Q, Zhao S, Tao T, Lu R, Gao Y, Wu H, Guo L. Enhanced hypoglycemic effects of konjac glucomannan combined with Polygonatum cyrtonema Hua polysaccharide in complete nutritional liquid diet fed type 2 diabetes mice. Int J Biol Macromol. 2024 May; 266(Pt 1):131121.